High-performance liquid chromatography-tandem mass spectroscopy (HPLC–MS/MS) chromatography reveals pyrrolizidine alkaloids (PA)/pyrrolizidine alkaloid N-oxides (PANO) toxin risks in 63 tea samples.
|Articles|November 1, 2001
- LCGC North America-11-01-2001
- Volume 19
- Issue 11
What Drives a Separation — the Stationary Phase or the Mobile Phase?
Author(s)Jessica Wysocki
The author investigates solute partitioning between the mobile and stationary phases to determine the driving force of reversed-phase liquid chromatography separations.
Advertisement
Articles in this issue
almost 25 years ago
Striving to Validate Nutraceuticalsalmost 25 years ago
Marketplacealmost 25 years ago
Retaining Polar Compoundsalmost 25 years ago
Handling Fast PeaksAdvertisement
Related to this article
Advances in DNA/RNA chromatography columns led to stable, pure mRNA production, supporting the development of COVID-19 vaccines rapidly.
Steven Ray Wilson's AFFL LC–MS system runs thousands of injections per column, but he calls validation and standardization the field's real barrier.
Kinjal Bhatt and Ina Varfaj describe imposter syndrome fading through repeated exposure and conference talk rather than a single breakthrough moment.
Mass spectrometry can teach core chemistry concepts beyond technique training or product characterization, though adoption barriers remain.
Automated sequential tube sampling and chemometrics supplement GC–MS, adding time profiling and fast product-line comparison for real-world insight.
Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.
Revisiting insertion distance for methanol and methylene chloride in GC analysis and confirming that insertion depth strongly affects response and reproducibility.
Advertisement
Advertisement